Lumos Pharma (LUMO) News Today $4.32 -0.01 (-0.23%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Hold Rating on Lumos Pharma Amid Financial Challenges and Strategic Merger with Double Point VenturesNovember 10, 2024 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Lumos Pharma Inc. – LUMONovember 6, 2024 | globenewswire.comLumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62ⁿᵈ Annual ESPE Meeting 2024October 31, 2024 | markets.businessinsider.comHC Wainwright & Co. Downgrades Lumos Pharma (LUMO)October 26, 2024 | msn.comJones Trading Downgrades Lumos Pharma (LUMO)October 24, 2024 | msn.comLumos Pharma downgraded to Neutral from Buy at H.C. WainwrightOctober 24, 2024 | markets.businessinsider.comDPV set to acquire Lumos Pharma for $38mOctober 24, 2024 | msn.comLumos Pharma Shares Rally After Double Point DealOctober 23, 2024 | marketwatch.comDouble Point to Buy Lumos Pharma for $38M as FDA OKs Lumos Drug TrialOctober 23, 2024 | marketwatch.comLumos Pharma enters merger agreement with Double Point Ventures to go privateOctober 23, 2024 | markets.businessinsider.comLumos Pharma downgraded to Hold from Buy at JonesResearchOctober 23, 2024 | markets.businessinsider.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Lumos Pharma, Inc.October 23, 2024 | prnewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MMLP and LUMO on Behalf of ShareholdersOctober 23, 2024 | prnewswire.comLUMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Lumos Pharma, Inc. Is Fair to ShareholdersOctober 23, 2024 | businesswire.comLumos Pharma (NASDAQ:LUMO) Stock Quotes, Forecast and News SummaryOctober 21, 2024 | benzinga.comLumos Pharma Inc (LUMO) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial PrudenceOctober 9, 2024 | finance.yahoo.comLumos Pharma: A Strong Buy on Innovative Drug Prospects and Solid FinancialsSeptember 29, 2024 | markets.businessinsider.comLumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024September 25, 2024 | globenewswire.comLumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment ConferenceAugust 15, 2024 | globenewswire.comLumos Pharma, Inc. (NASDAQ:LUMO) Q2 2024 Earnings Call TranscriptAugust 3, 2024 | insidermonkey.comLumos Pharma, Inc. (LUMO) Q2 2024 Earnings Call TranscriptAugust 1, 2024 | seekingalpha.comLumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development UpdateAugust 1, 2024 | finance.yahoo.comLumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development UpdateAugust 1, 2024 | globenewswire.comLumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024July 23, 2024 | globenewswire.comCrowdStrike CEO apologizes for tech outage, says systems should be recovering -NBCJuly 19, 2024 | msn.comLumos Pharma, Inc.: Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024May 21, 2024 | finanznachrichten.deLumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024May 20, 2024 | globenewswire.comLumos Pharma Inc (LUMO) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial ...May 16, 2024 | finance.yahoo.comLumos Pharma, Inc.: Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial ResultsMay 15, 2024 | finanznachrichten.deLUMO Stock Earnings: Lumos Pharma Misses EPS, Misses Revenue for Q1 2024May 14, 2024 | msn.comLumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial ResultsMay 14, 2024 | globenewswire.comLumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024May 9, 2024 | globenewswire.comLumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical MeetingsApril 18, 2024 | globenewswire.comLumos Pharma’s LUM-201 Receives ‘Buy’ Rating on Strong Market Position and Promising Trial OutcomesMarch 21, 2024 | markets.businessinsider.comLumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042March 20, 2024 | globenewswire.comBAT set to sell stake in India's ITC stake as soon as this week, Bloomberg reportsMarch 11, 2024 | sg.news.yahoo.comLumos Pharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsMarch 10, 2024 | finance.yahoo.comLumos Pharma, Inc. (LUMO) Q4 2023 Earnings Call TranscriptMarch 9, 2024 | seekingalpha.comLumos Pharma, Inc.: Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development UpdateMarch 8, 2024 | finanznachrichten.deLumos Pharma, Inc. (NASDAQ:LUMO) Q4 2023 Earnings Call TranscriptMarch 8, 2024 | finance.yahoo.comQ4 2023 Lumos Pharma Inc Earnings CallMarch 8, 2024 | uk.finance.yahoo.comLUMO Stock Earnings: Lumos Pharma Misses EPS for Q4 2023March 7, 2024 | investorplace.comLumos Pharma: Q4 Earnings InsightsMarch 7, 2024 | benzinga.comLumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development UpdateMarch 7, 2024 | globenewswire.comEarnings Preview: Lumos PharmaMarch 6, 2024 | benzinga.comLumos Pharma FY 2023 Earnings PreviewMarch 6, 2024 | msn.comAxoSim Appoints Two Biotech Industry Veterans as Co-Chairs of Its Board of DirectorsFebruary 28, 2024 | finance.yahoo.comLumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024February 26, 2024 | globenewswire.comExact Sciences (EXAS) Reports Q4 Loss, Tops Revenue EstimatesFebruary 21, 2024 | msn.comLumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences ConferenceFebruary 5, 2024 | finance.yahoo.com Get Lumos Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LUMO and its competitors with MarketBeat's FREE daily newsletter. Email Address This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here LUMO Media Mentions By Week LUMO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LUMO News Sentiment▼0.000.46▲Average Medical News Sentiment LUMO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LUMO Articles This Week▼01▲LUMO Articles Average Week Get Lumos Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LUMO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Equillium News Today Black Diamond Therapeutics News Today Inventiva News Today Acumen Pharmaceuticals News Today Elutia News Today FitLife Brands News Today Incannex Healthcare News Today Sagimet Biosciences News Today Cardiol Therapeutics News Today Puma Biotechnology News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LUMO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lumos Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lumos Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LUMO Stock Alerts